Cytodyn Inc (CYDY)

[The Blue Baron]

Everyone is focusing on Coronavirus. It should also be noted the press release states the 2 companies will explore working on cancer. I suspect this may be a way for CYDY to avoid further dilution to pay for a much larger trial. Smart move by Nader Pourhassan preserving shareholder value.

This is obviously a desperate situation for China. How long will it take to find a few patients to test Leronlimab on? It’s safe, what have they got to lose? NP is doing what he can to prove Leronlimab works.

Once the BLA is submitted and hopefully approved, some on here will be singing a different tune. I would venture to guess; this investment has a much higher payout potential than many others based solely on return.

“CytoDyn and Longen will begin exploring opportunities for leronlimab for the treatment of the 2019 Novel Coronavirus (2019-nCoV) and cancer.”